Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma

Pharmacologic treatment of asthma should be done with a stepwise approach recommended in treatment guidelines. If inhaled corticosteroids (ICSs) alone are not adequate, ICSs in combination with long-acting β-agonists (LABAs) are now established and widely used as the next step in effective controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ricardo Antonio, Corren, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196884/
https://www.ncbi.nlm.nih.gov/pubmed/25328383
http://dx.doi.org/10.2147/DDDT.S36556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196884/
https://www.ncbi.nlm.nih.gov/pubmed/25328383
http://dx.doi.org/10.2147/DDDT.S36556

Ejemplares similares